| 000 | 01675 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518040410.0 | ||
| 264 | 0 | _c20200318 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1471-2261 | ||
| 024 | 7 |
_a10.1186/s12872-019-1098-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Yong | |
| 245 | 0 | 0 |
_aSignificant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. _h[electronic resource] |
| 260 |
_bBMC cardiovascular disorders _c05 2019 |
||
| 300 |
_a107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBeijing |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aChemokine CCL2 _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Admission |
| 650 | 0 | 4 | _aPercutaneous Coronary Intervention |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 |
_aST Elevation Myocardial Infarction _xblood |
| 650 | 0 | 4 | _aStroke Volume |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aVentricular Function, Left |
| 700 | 1 | _aHu, Chengping | |
| 700 | 1 | _aDu, Yu | |
| 700 | 1 | _aZhang, Jianwei | |
| 700 | 1 | _aLiu, Jinxing | |
| 700 | 1 | _aHan, Hongya | |
| 700 | 1 | _aZhao, Yingxin | |
| 773 | 0 |
_tBMC cardiovascular disorders _gvol. 19 _gno. 1 _gp. 107 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12872-019-1098-z _zAvailable from publisher's website |
| 999 |
_c29678986 _d29678986 |
||